Evaluation of the Frequency of Limitation of Activity in Patients With Persistent Asthma

Completed

• Conditions: Persistent Asthma

• Registration Number: NCT01078688
• Lead Sponsor: AstraZeneca

Brief Summary

Evaluation of the frequency of limitation of activity, depending on gender and age-group, in patients with persistent asthma consulting a general practitioner

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2010-02-25
• Study Start: 2010-03
• Study First Submitted QC: 2010-03-01
• Study First Posted: 2010-03-02
• Primary Completion: 2010-10
• Study Completion: 2010-10
• Status Verified: 2013-01
• Last Update Submitted: 2013-01-28
• Last Update Posted: 2013-01-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1942

Inclusion Criteria

• persistent asthma receiving long-term maintenance treatment with inhaled steroids (alone or in combination with other drugs)

Exclusion Criteria

• Patients with a diagnosis of COPD

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To describe, depending on gender and age-group, the nature of the activities limited, the degree of limitation and the impact on the patient's daily life.	Once during only visit
To describe the frequency of limitations of activities in patients with persistent asthma depending on gender and age-group.	Last 3 months / once

Secondary Outcome Measures

Name	Time	Method
To describe the main characteristics and initial management for all patients of the survey	Once during only visit
To describe the nature of the activities limited, the degree of limitation and the impact on the patient's daily life according to the level of asthma control	Once during only visit
To describe, depending on gender and age-group, the activities that need to be specifically investigated in routine clinical practice due to their greater impact on the patient's quality of life, and which could indicate poorly controlled asthma	Once during only visit

Trial Locations

Locations (1)

Research Site; 🇫🇷 Yerville, France